Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries

Copyright © 2010 John Wiley & Sons, Inc.

Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries

Editor(s): Pete Harpum

Published Online: 29 MAR 2010

Print ISBN: 9780470049662

Online ISBN: 9780470603789

DOI: 10.1002/9780470603789

About this Book

Product Information

About The Product

This book describes the way that pharmaceutical projects and programs are currently managed, and offers views from many highly experienced practitioners from within the industry on future directions for drug program management. The book integrates portfolio, program, and project management processes as fundamental for effective and efficient drug product development. Contributing expert authors provide their view of how the projectization approach can be taken forward by the drug industry over the coming years.

Table of contents

    1. You have free access to this content
      Frontmatter (pages i–xvi)

    1. You have free access to this content
      Color Plates (pages c1–c2)

  3. Part One: The Life Science Industry Context for Portfolio, Program, and Project Management

    1. You have free access to this content
      Part Introduction (pages 1–2)

    2. Chapter 1

      A Review of Project Management in Life Science Industry Sectors (pages 3–19)

      Thomas R. Dunson

    3. Chapter 2

      The Impact of Organizational Size on Drug Project Management (pages 21–32)

      Eric Morfin

    4. Chapter 3

      Drug Development in Biotechnology and How We Can Do It Better (pages 33–47)

      Susan Linna

  4. Part Two: The Portfolio, Program, and Project Management Approaches and Processes

    1. You have free access to this content
      Part Introduction (pages 49–51)

    2. Chapter 4

      An Overview of the Organization and Processes of Portfolio, Program, and Project Management (pages 53–57)

      Pete Harpum

    3. Chapter 5

      Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market (pages 59–83)

      Dr. John Bennett

    4. Chapter 6

      Program Management in Drug Development (pages 85–99)

      Pauline Stewart-Long

    5. Chapter 7

      Project Control (pages 101–134)

      Martin Powell

    6. Chapter 8

      Managing Uncertainty in Drug Projects (pages 135–153)

      Pete Harpum and Thomas R. Dunson

    7. Chapter 9

      Managing Drug Safety Risk (pages 155–174)

      Thomas R. Dunson and Eric Morfin

    8. Chapter 10

      Developing Program Strategy (pages 175–196)

      Pete Harpum

    9. Chapter 11

      Developing Products with “Added Value” (pages 197–224)

      Trevor J. Brown and Stephen Allport

  5. Part Three: Integrating the Processes

    1. You have free access to this content
      Part Introduction (page 225)

    2. Chapter 12

      Integrated Business Processes to Support Cross-Functional Drug Development (pages 227–238)

      Martin D. Hynes

    3. Chapter 13

      Integrated Drug Development: From Cradle to Grave and from Lab to Market (pages 239–258)

      Stephen Allport and Terry Cooke-Davies

    4. Chapter 14

      The Development of P3M Capability in Drug Development Organizations (pages 259–285)

      John Arrowsmith, Patrick Grogan and Bob Moore

    5. Chapter 15

      Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations (pages 287–309)

      Pete Harpum, Ashley Jamieson and Inge Fisher

    1. You have free access to this content
      Bibliography (pages 311–312)

    1. You have free access to this content
      Index (pages 313–331)

SEARCH